Haloperidol

Overview

Primary Characterstics

Haloperidol is also known as Aloperidolo.Haloperidol is also known as Aloperidolo. It is of Synthetic origin and belongs to Butyrophenone. It belongs to D2 antagonist pharmacological group on the basis of mechanism of action and also classified in Psychotherapeutic Drugs pharmacological group.The Molecular Weight of Haloperidol is 375.90.

Its pKa is 8.3.

Indications

Pharmacokinetics

Contraindications

Drug Interactions

Side Effects

Dosage

Haloperidol's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
3 to 10 mg	6.5 (6.5)	24 hourly	PO	Maintenance
10 to 15 mg	12 (12.5)	24 hourly	PO	Initially
Paedriatic Dosage (20kg)
0.025 to 5 mg/kg	2.5 (2.5125)	12 hourly	Intra Muscular	Not recommended under 3 yrs.children
0.025 to 5 mg/kg	2.5 (2.5125)	12 hourly	Intra Venous	Not recommended under 3yrs children
25 to 0 mg/kg	12 (12.5)	12 hourly	Oral	Maximum of 150 ug/kg
Neonatal Dosage (3kg)
				Not recommended in this age group

High Risk Groups

Warning / Precautions

Storage Conditions

Interference in Pathology

Brands / Trade Names of Haloperidol

Manufacturers of Haloperidol in Pakistan

Adamjee Caraway Genetics Glitz Mediceena Pharmedic Reko Searle Tagma Xenon

Previous Drug Generic - Next Drug Generic